Valproic acid prevents NMDA-Induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling

American Journal of Pathology

Volumn 185, Issue 3, 2015, Pages 756-764

  Kimura, Atsuko ^a   Namekata, Kazuhiko ^a   Guo, Xiaoli ^a   Noro, Takahiko ^a   Harada, Chikako ^a   Harada, Takayuki ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CELL RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; VALPROIC ACID; N METHYLASPARTIC ACID; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; ELECTRORETINOGRAPHY; EXCITOTOXICITY; GLAUCOMA; GLIA CELL; HISTOPATHOLOGY; IMAGING; KNOCKOUT MOUSE; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; UPREGULATION; VISUAL IMPAIRMENT; ANIMAL; DRUG EFFECTS; METABOLISM; PATHOLOGY;

ANIMALS; CELL DEATH; MICE; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; RECEPTOR, TRKB; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION; UP-REGULATION; VALPROIC ACID;

EID: 84920787259     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.11.005     Document Type: Article

References (62)

1. R.M. Pinder, R.N. Brogden, T.M. Speight, and G.S. Avery Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy Drugs 13 1977 81 123
2. C.T. Chiu, Z. Wang, J.G. Hunsberger, and D.M. Chuang Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder Pharmacol Rev 65 2013 105 142
3. J. Hoffmann, S. Akerman, and P.J. Goadsby Efficacy and mechanism of anticonvulsant drugs in migraine Expert Rev Clin Pharmacol 7 2014 191 201
4. A.M. Waszkielewicz, A. Gunia, K. Sloczyńska, and H. Marona Evaluation of anticonvulsants for possible use in neuropathic pain Curr Med Chem 18 2011 4344 4358
5. N. Gurvich, and P.S. Klein Lithium and valproic acid: parallels and contrasts in diverse signaling contexts Pharmacol Ther 96 2002 45 66
6. M. Göttlicher, S. Minucci, P. Zhu, O.H. Krämer, A. Schimpf, S. Giavara, J.P. Sleeman, F. Lo Coco, C. Nervi, P.G. Pelicci, and T. Heinzel Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells EMBO J 20 2001 6969 6978
7. C.J. Phiel, F. Zhang, E.Y. Huang, M.G. Guenther, M.A. Lazar, and P.S. Klein Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen J Biol Chem 276 2001 36734 36741
8. S. Chen, H. Wu, D. Klebe, Y. Hong, and J. Zhang Valproic Acid: a new candidate of therapeutic application for the acute central nervous system injuries Neurochem Res 39 2014 1621 1633
9. B. Monti, V. Gatta, F. Piretti, S.S. Raffaelli, M. Virgili, and A. Contestabile Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein Neurotox Res 17 2010 130 141
10. H. Qing, G. He, P.T. Ly, C.J. Fox, M. Staufenbiel, F. Cai, Z. Zhang, S. Wei, X. Sun, C.H. Chen, W. Zhou, K. Wang, and W. Song Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models J Exp Med 205 2008 2781 2789
11. X.Z. Zhang, X.J. Li, and H.Y. Zhang Valproic acid as a promising agent to combat Alzheimer's disease Brain Res Bull 81 2010 3 6
12. Z. Long, M. Zheng, L. Zhao, P. Xie, C. Song, Y. Chu, W. Song, and G. He Valproic acid attenuates neuronal loss in the brain of APP/PS1 double transgenic Alzheimer's disease mice model Curr Alzheimer Res 10 2013 261 269
13. H.A. Quigley, and A.T. Broman The number of people with glaucoma worldwide in 2010 and 2020 Br J Ophthalmol 90 2006 262 267
14. S.W. John, R.S. Smith, O.V. Savinova, N.L. Hawes, B. Chang, D. Turnbull, M. Davisson, T.H. Roderick, and J.R. Heckenlively Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice [Erratum appeared in Invest Ophthalmol Vis Sci 1998, 39:1641] Invest Ophthalmol Vis Sci 39 1998 951 962
15. E. WoldeMussie, G. Ruiz, M. Wijono, and L.A. Wheeler Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension Invest Ophthalmol Vis Sci 42 2001 2849 2855
16. E. Garcia-Valenzuela, S. Shareef, J. Walsh, and S.C. Sharma Programmed cell death of retinal ganglion cells during experimental glaucoma Exp Eye Res 61 1995 33 44
17. J.C. Morrison, C.G. Moore, L.M. Deppmeier, B.G. Gold, C.K. Meshul, and E.C. Johnson A rat model of chronic pressure-induced optic nerve damage Exp Eye Res 64 1997 85 96
18. B.E. Klein, R. Klein, W.E. Sponsel, T. Franke, L.B. Cantor, J. Martone, and M.J. Menage Prevalence of glaucoma. The Beaver Dam Eye Study Ophthalmology 99 1992 1499 1504
19. A. Iwase, Y. Suzuki, M. Araie, T. Yamamoto, H. Abe, S. Shirato, Y. Kuwayama, H.K. Mishima, H. Shimizu, G. Tomita, Y. Inoue, Y. Kitazawa Tajimi Study Group, Japan Glaucoma Society The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study Ophthalmology 111 2004 1641 1648
20. T. Harada, C. Harada, K. Nakamura, H.M. Quah, A. Okumura, K. Namekata, T. Saeki, M. Aihara, H. Yoshida, A. Mitani, and K. Tanaka The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma J Clin Invest 117 2007 1763 1770
21. C. Harada, K. Namekata, X. Guo, H. Yoshida, Y. Mitamura, Y. Matsumoto, K. Tanaka, H. Ichijo, and T. Harada ASK1 deficiency attenuates neural cell death in GLAST-deficient mice, a model of normal tension glaucoma Cell Death Differ 17 2010 1751 1759
22. K. Semba, K. Namekata, X. Guo, C. Harada, T. Harada, and Y. Mitamura Renin-angiotensin system regulates neurodegeneration in a mouse model of normal tension glaucoma Cell Death Dis 5 2014 e1333
23. K. Semba, K. Namekata, A. Kimura, C. Harada, Y. Mitamura, and T. Harada Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma Cell Death Dis 5 2014 e1341
24. Y. Li, C.L. Schlamp, and R.W. Nickells Experimental induction of retinal ganglion cell death in adult mice Invest Ophthalmol Vis Sci 40 1999 1004 1008
25. K. Namekata, A. Kimura, K. Kawamura, X. Guo, C. Harada, K. Tanaka, and T. Harada Dock3 attenuates neural cell death due to NMDA neurotoxicity and oxidative stress in a mouse model of normal tension glaucoma Cell Death Differ 20 2013 1250 1256
26. M.F. Cordeiro, L. Guo, V. Luong, G. Harding, W. Wang, H.E. Jones, S.E. Moss, A.M. Sillito, and F.W. Fitzke Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration Proc Natl Acad Sci USA 101 2004 13352 13356
27. F. Schuettauf, K. Quinto, R. Naskar, and D. Zurakowski Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model Vision Res 42 2002 2333 2337
28. M. Seki, and S.A. Lipton Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma Prog Brain Res 173 2008 495 510
29. N.N. Osborne Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned Acta Ophthalmol 87 2009 450 454
30. L. Cheng, P. Sapieha, P. Kittlerova, W.W. Hauswirth, and A. Di Polo TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo J Neurosci 22 2002 3977 3986
31. G. Parrilla-Reverter, M. Agudo, P. Sobrado-Calvo, M. Salinas-Navarro, M.P. Villegas-Pérez, and M. Vidal-Sanz Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study Exp Eye Res 89 2009 32 41
32. K.R. Martin, H.A. Quigley, D.J. Zack, H. Levkovitch-Verbin, J. Kielczewski, D. Valenta, L. Baumrind, M.E. Pease, R.L. Klein, and W.W. Hauswirth Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model Invest Ophthalmol Vis Sci 44 2003 4357 4365
33. C. Harada, X. Guo, K. Namekata, A. Kimura, K. Nakamura, K. Tanaka, L.F. Parada, and T. Harada Glia- and neuron-specific functions of TrkB signalling during retinal degeneration and regeneration Nat Commun 2 2011 189
34. T. Katome, K. Namekata, X. Guo, K. Semba, D. Kittaka, K. Kawamura, A. Kimura, C. Harada, H. Ichijo, Y. Mitamura, and T. Harada Inhibition of ASK1-p38 pathway prevents neural cell death following optic nerve injury Cell Death Differ 20 2013 270 280
35. C. Harada, K. Nakamura, K. Namekata, A. Okumura, Y. Mitamura, Y. Iizuka, K. Kashiwagi, K. Yoshida, S. Ohno, A. Matsuzawa, K. Tanaka, H. Ichijo, and T. Harada Role of apoptosis signal-regulating kinase 1 in stress-induced neural cell apoptosis in vivo Am J Pathol 168 2006 261 269
36. T. Harada, C. Harada, S. Kohsaka, E. Wada, K. Yoshida, S. Ohno, H. Mamada, K. Tanaka, L.F. Parada, and K. Wada Microglia-Müller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration J Neurosci 22 2002 9228 9236
37. X. Guo, K. Nakamura, K. Kohyama, C. Harada, H.A. Behanna, D.M. Watterson, Y. Matsumoto, and T. Harada Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis Neurosci Res 59 2007 457 466
38. E.E. Sutter, and M.A. Bearse Jr. The optic nerve head component of the human ERG Vision Res 39 1999 419 436
39. M.A. Bearse Jr.; E.E. Sutter, D. Sim, and R. Stamper Glaucomatous dysfunction revealed in higher order components of the electroretinogram. Vision Science and Its Applications. OSA Technical Digest Series 1996 Optical Society of America Washington, DC 105 107
40. P.S. Chen, G.S. Peng, G. Li, S. Yang, X. Wu, C.C. Wang, B. Wilson, R.B. Lu, P.W. Gean, D.M. Chuang, and J.S. Hong Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes Mol Psychiatry 11 2006 1116 1125
41. S. Yasuda, M.H. Liang, Z. Marinova, A. Yahyavi, and D.M. Chuang The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons Mol Psychiatry 14 2009 51 59
42. H. Noh, and H. Seo Age-dependent effects of valproic acid in Alzheimer's disease (AD) mice are associated with nerve growth factor (NGF) regulation Neuroscience 266 2014 255 265
43. Z.Z. Zhang, Y.Y. Gong, Y.H. Shi, W. Zhang, X.H. Qin, and X.W. Wu Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush Neuroscience 224 2012 282 293
44. S.M. Massa, T. Yang, Y. Xie, J. Shi, M. Bilgen, J.N. Joyce, D. Nehama, J. Rajadas, and F.M. Longo Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents J Clin Invest 120 2010 1774 1785
45. S.W. Jang, X. Liu, M. Yepes, K.R. Shepherd, G.W. Miller, Y. Liu, W.D. Wilson, G. Xiao, B. Blanchi, Y.E. Sun, and K. Ye A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone Proc Natl Acad Sci USA 107 2010 2687 2692
46. T. Harada, C. Harada, and L.F. Parada Molecular regulation of visual system development: more than meets the eye Genes Dev 21 2007 367 378
47. M. Almasieh, C.J. Lieven, L.A. Levin, and A. Di Polo A cell-permeable phosphine-borane complex delays retinal ganglion cell death after axonal injury through activation of the pro-survival extracellular signal-regulated kinases 1/2 pathway J Neurochem 118 2011 1075 1086
48. A. Bringmann, I. Iandiev, T. Pannicke, A. Wurm, M. Hollborn, P. Wiedemann, N.N. Osborne, and A. Reichenbach Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects Prog Retin Eye Res 28 2009 423 451
49. D. Goldman Müller glial cell reprogramming and retina regeneration Nat Rev Neurosci 15 2014 431 442
50. A. Di Polo, L.J. Aigner, R.J. Dunn, G.M. Bray, and A.J. Aguayo Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells Proc Natl Acad Sci USA 95 1998 3978 3983
51. A. Lambiase, L. Aloe, M. Centofanti, V. Parisi, F. Mantelli, V. Colafrancesco, G.L. Manni, M.G. Bucci, S. Bonini, and R. Levi-Montalcini Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma Proc Natl Acad Sci USA 106 2009 13469 13474
52. A. Goyal, A. Srivastava, R. Sihota, and J. Kaur Evaluation of oxidative stress markers in aqueous humor of primary open angle glaucoma and primary angle closure glaucoma patients Curr Eye Res 39 2014 823 829
53. D.M. Inman, W.S. Lambert, D.J. Calkins, and P.J. Horner alpha-Lipoic acid antioxidant treatment limits glaucoma-related retinal ganglion cell death and dysfunction PLoS One 8 2013 e65389
54. Z. Zhang, X. Qin, X. Zhao, N. Tong, Y. Gong, W. Zhang, and X. Wu Valproic acid regulates antioxidant enzymes and prevents ischemia/reperfusion injury in the rat retina Curr Eye Res 37 2012 429 437
55. S. Suda, K. Katsura, T. Kanamaru, M. Saito, and Y. Katayama Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation Eur J Pharmacol 707 2013 26 31
56. Z. Zhang, N. Tong, Y. Gong, Q. Qiu, L. Yin, X. Lv, and X. Wu Valproate protects the retina from endoplasmic reticulum stress-induced apoptosis after ischemia-reperfusion injury Neurosci Lett 504 2011 88 92
57. J.Y. Lee, S. Maeng, S.R. Kang, H.Y. Choi, T.H. Oh, B.G. Ju, and T.Y. Yune Valproic acid protects motor neuron death by inhibiting oxidative stress and endoplasmic reticulum stress-mediated cytochrome C release after spinal cord injury J Neurotrauma 31 2014 582 594
58. B. Monti, E. Polazzi, and A. Contestabile Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection Curr Mol Pharmacol 2 2009 95 109
59. A.M. VanDongen, M.G. VanErp, and R.A. Voskuyl Valproate reduces excitability by blockage of sodium and potassium conductance Epilepsia 27 1986 177 182
60. L.M. Tian, and K.A. Alkadhi Valproic acid inhibits the depolarizing rectification in neurons of rat amygdala Neuropharmacology 33 1994 1131 1138
61. J. Biermann, P. Grieshaber, U. Goebel, G. Martin, S. Thanos, S. Di Giovanni, and W.A. Lagrèze Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells Invest Ophthalmol Vis Sci 51 2010 526 534
62. K. Semba, K. Namekata, A. Kimura, C. Harada, T. Katome, H. Yoshida, Y. Mitamura, and T. Harada Dock3 overexpression and p38 MAPK inhibition synergistically stimulate neuroprotection and axon regeneration after optic nerve injury Neurosci Lett 581 2014 89 93